14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
SSL vs CBT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Sasol Limited (SSL) is the stronger overall head-to-head candidate over Cabot Corporation (CBT) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SSL carries a Unified Composite Score of 49.5/100 (HOLD) at $11.52 (4.1x Forward P/E, 17.1% operating margin), whereas CBT carries 49.0/100 (HOLD) at $70.48 (9.1x Forward P/E, 14.8% operating margin).
Technical & Structure Timing Caution: SSL trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 24.6); meanwhile CBT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SSL vs CBT. Trailing 12-month operating profitability (SSL 17.1% vs CBT 14.8%) and valuation multiples (SSL 4.1x vs CBT 9.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Specialty Chemicals value chain with $3.7B market capitalization and 14.8% operating margin.
OpEx & R&D Reinvestment8.7% of Rev ($326M)
90D Engineering Disclosures0 Published
Investor FAQ SSL vs CBT Key Questions & Quantitative Answers
As of Nov 20, 2026, Sasol Limited (SSL) is the stronger overall head-to-head candidate over Cabot Corporation (CBT) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SSL carries a Unified Composite Score of 49.5/100 (HOLD) at $11.52 (4.1x Forward P/E, 17.1% operating margin), whereas CBT carries 49.0/100 (HOLD) at $70.48 (9.1x Forward P/E, 14.8% operating margin). Technical & Structure Timing Caution: SSL trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 24.6); meanwhile CBT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SSL leads the Growth & Scale pillar: SSL posts +17.9% YoY revenue growth and +447.5% YoY earnings growth on $15.9B TTM revenue (43.8% gross margin, 17.1% operating margin), compared with CBT at +12.2% YoY revenue growth and +58.0% YoY earnings growth on $3.74B TTM revenue (23.5% gross margin, 14.8% operating margin). On trailing 12-month operating scale, SSL generates $15.9B in USD-normalized revenue versus $3.74B for CBT. In operating R&D and SG&A reinvestment, SSL deploys 26.7% of Rev ($4.25B) (0 90-day corporate R&D disclosures) versus 8.7% of Rev ($326M) (0 disclosures) for CBT.
SSL screens cheaper on headline valuation multiples. SSL trades at 4.1x Forward P/E, 10.6x Trailing P/E, 0.14x PEG, and 0.5x EV/Revenue (21.2% EBITDA margin), whereas CBT trades at 9.1x Forward P/E, 18.1x Trailing P/E, 1.00x PEG, and 1.0x EV/Revenue (20.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SSL (8.8% ROE) versus CBT (14.2% ROE) capital efficiency.
In options market volatility and institutional positioning, SSL carries 58.5% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.82β · 51% Vol realized risk). By comparison, CBT carries 29.0% implied volatility (43rd %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.47β · 36% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.